Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Minami

Showing results (361-370 of 500) with videos related to

Pageof 50
Sort By:
International Journal of Clinical Practice|December 19, 2014
Third heart sound in hospitalised patients with acute heart failure: insights from the ATTEND studyY Minami, K Kajimoto, N Sato, et al.
Japanese Circulation Journal|November 1, 1980
Hypercoagulability in patients with mitral stenosis -- from the viewpoint of the behavior of plasma antithrombin III and alpha2-plasmin inhibitorY Fukuda, Y Kuroiwa, K Okumiya, et al.
Molecular and Cellular Biology|November 20, 2001
Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinasesM Nomi, I Oishi, S Kani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 1999
H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cellsY Tanaka, Y Minami, S Mine, et al.
Rinsho Hoshasen. Clinical Radiography|September 1, 1979
[A case report: arterial embolization of early gastric cancer with massive gastric hemorrhage (author's transl)]H Yoshioka, H Uchida, M Sato, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|January 29, 2000
Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formationS Takeuchi, K Takeda, I Oishi, et al.
Cancer Gene Therapy|November 4, 2000
A novel strategy for cancer therapy by mutated mammalian degenerin gene transferM Horimoto, Y Sasaki, S Ugawa, et al.
The British Journal of Dermatology|February 26, 2018
Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitorsH Horikawa, Y Kurihara, T Funakoshi, et al.
Physical Review Letters|March 18, 2022
Cosmic Birefringence from the Planck Data Release 4P Diego-Palazuelos, J R Eskilt, Y Minami, et al.
Oncogene|February 22, 2007
The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272Y Minami, T Shimamura, K Shah, et al.
Pageof 50

Showing results (361-370 of 500) with videos related to

Sort By:
Pageof 50
International Journal of Clinical Practice|December 19, 2014
Third heart sound in hospitalised patients with acute heart failure: insights from the ATTEND studyY Minami, K Kajimoto, N Sato, et al.
Japanese Circulation Journal|November 1, 1980
Hypercoagulability in patients with mitral stenosis -- from the viewpoint of the behavior of plasma antithrombin III and alpha2-plasmin inhibitorY Fukuda, Y Kuroiwa, K Okumiya, et al.
Molecular and Cellular Biology|November 20, 2001
Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinasesM Nomi, I Oishi, S Kani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 1999
H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cellsY Tanaka, Y Minami, S Mine, et al.
Rinsho Hoshasen. Clinical Radiography|September 1, 1979
[A case report: arterial embolization of early gastric cancer with massive gastric hemorrhage (author's transl)]H Yoshioka, H Uchida, M Sato, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|January 29, 2000
Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formationS Takeuchi, K Takeda, I Oishi, et al.
Cancer Gene Therapy|November 4, 2000
A novel strategy for cancer therapy by mutated mammalian degenerin gene transferM Horimoto, Y Sasaki, S Ugawa, et al.
The British Journal of Dermatology|February 26, 2018
Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitorsH Horikawa, Y Kurihara, T Funakoshi, et al.
Physical Review Letters|March 18, 2022
Cosmic Birefringence from the Planck Data Release 4P Diego-Palazuelos, J R Eskilt, Y Minami, et al.
Oncogene|February 22, 2007
The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272Y Minami, T Shimamura, K Shah, et al.
Pageof 50